ReShape Lifesciences Statistics
Total Valuation
RSLS has a market cap or net worth of $2.55 million. The enterprise value is $2.00 million.
Important Dates
The last earnings date was Thursday, November 14, 2024, after market close.
Earnings Date | Nov 14, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
RSLS has 506,675 shares outstanding. The number of shares has increased by 1,218.16% in one year.
Current Share Class | 506,675 |
Shares Outstanding | 506,675 |
Shares Change (YoY) | +1,218.16% |
Shares Change (QoQ) | +16.51% |
Owned by Insiders (%) | 7.46% |
Owned by Institutions (%) | 0.45% |
Float | 468,861 |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.31 |
Forward PS | 0.79 |
PB Ratio | 1.72 |
P/TBV Ratio | 1.72 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 0.24 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.33, with a Debt / Equity ratio of 0.13.
Current Ratio | 1.33 |
Quick Ratio | 0.52 |
Debt / Equity | 0.13 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -309.28% and return on invested capital (ROIC) is -196.22%.
Return on Equity (ROE) | -309.28% |
Return on Assets (ROA) | -73.66% |
Return on Capital (ROIC) | -196.22% |
Revenue Per Employee | $282,172 |
Profits Per Employee | -$243,690 |
Employee Count | 29 |
Asset Turnover | 1.22 |
Inventory Turnover | 0.85 |
Taxes
In the past 12 months, RSLS has paid $65,000 in taxes.
Income Tax | 65,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.79% in the last 52 weeks. The beta is 1.35, so RSLS's price volatility has been higher than the market average.
Beta (5Y) | 1.35 |
52-Week Price Change | -63.79% |
50-Day Moving Average | 6.02 |
200-Day Moving Average | 9.50 |
Relative Strength Index (RSI) | 40.09 |
Average Volume (20 Days) | 157,633 |
Short Selling Information
The latest short interest is 25,009, so 4.94% of the outstanding shares have been sold short.
Short Interest | 25,009 |
Short Previous Month | 14,680 |
Short % of Shares Out | 4.94% |
Short % of Float | 5.33% |
Short Ratio (days to cover) | 0.22 |
Income Statement
In the last 12 months, RSLS had revenue of $8.18 million and -$7.07 million in losses. Loss per share was -$13.95.
Revenue | 8.18M |
Gross Profit | 5.58M |
Operating Income | -7.92M |
Pretax Income | -10.87M |
Net Income | -7.07M |
EBITDA | -7.90M |
EBIT | -7.92M |
Loss Per Share | -$13.95 |
Full Income Statement Balance Sheet
The company has $743,000 in cash and $191,000 in debt, giving a net cash position of $552,000 or $1.09 per share.
Cash & Cash Equivalents | 743,000 |
Total Debt | 191,000 |
Net Cash | 552,000 |
Net Cash Per Share | $1.09 |
Equity (Book Value) | 1.49M |
Book Value Per Share | 2.93 |
Working Capital | 1.31M |
Full Balance Sheet Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross margin is 68.19%, with operating and profit margins of -96.80% and -86.36%.
Gross Margin | 68.19% |
Operating Margin | -96.80% |
Pretax Margin | -85.57% |
Profit Margin | -86.36% |
EBITDA Margin | -96.49% |
EBIT Margin | -96.80% |
FCF Margin | -167.65% |